{
    "title": "103_hr615",
    "content": "The National Breast Cancer Strategy Act of 1993 establishes the Office of Breast Cancer and National Breast Cancer Commission under Title I. The Act also amends the Public Health Service Act to include the establishment of the Office of Breast Cancer. The National Breast Cancer Strategy Act of 1993 establishes the Office of Breast Cancer within the Office of the Assistant Secretary for Health. The Secretary appoints a Director for the Office, who coordinates activities related to breast cancer with the National Cancer Institute and other government agencies, public entities, and private entities. Additionally, the Act establishes the National Breast Cancer Commission under Title XVII of the Public Health Service Act. The National Breast Cancer Strategy Act of 1993 establishes the National Breast Cancer Commission under Title XVII of the Public Health Service Act. The National Breast Cancer Commission, established under the National Breast Cancer Strategy Act of 1993, conducts a study on breast cancer prevention, detection, treatment, education, and research. The Commission will submit a report with study results and recommendations to the President and Congress within a year of member appointments. The National Breast Cancer Commission, established under the National Breast Cancer Strategy Act of 1993, consists of 5 members appointed by the President. 3 members are nonvoting, including the Secretaries of Health and Human Services, Veterans Affairs, and Defense. In case of a tie, the Secretary of Health and Human Services becomes a voting member. The remaining 2 members are selected from the general public based on their qualifications. The National Breast Cancer Commission, established in 1993, consists of 5 members appointed by the President. The Commission includes nonvoting members from the Secretaries of Health and Human Services, Veterans Affairs, and Defense. In case of a tie, the Secretary of Health and Human Services becomes a voting member. Additional members are selected from the public based on qualifications. The appointment process involves recommendations from Congressional leaders and committee members with jurisdiction over relevant laws. The National Breast Cancer Commission, established in 1993, consists of 5 members appointed by the President. The Commission includes nonvoting members from relevant government departments. The appointment process involves recommendations from Congressional leaders and committees with jurisdiction over relevant laws. Committees with jurisdiction over laws related to veterans' health care, Medicaid, and public health service appoint qualified individuals to serve on the Commission. The Commission, appointed by the Speaker of the House and the President pro tempore of the Senate, covers various fields such as medicine, science, law, ethics, health care, and social services. Members serve for the life of the Commission, vacancies are filled in the same manner as the original appointment, a Chairman is selected within 15 days of appointment, and a quorum consists of 7 members. The Commission, appointed by the Speaker of the House and the President pro tempore of the Senate, covers various fields such as medicine, science, law, ethics, health care, and social services. Members serve for the life of the Commission, vacancies are filled in the same manner as the original appointment, a Chairman is selected within 15 days of appointment, and a quorum consists of 7 members. The Commission shall hold meetings as needed, with members receiving travel expenses and per diem while on duty. The Commission members must be appointed within 60 days of the enactment of the section, and the Commission will cease to exist 60 days after submitting its final report. TITLE II--DUTIES OF DIRECTOR OF THE NATIONAL CANCER INSTITUTE RELATING TO BREAST CANCER\n\nSEC. 201. PROVISIONS FOR FULL FUNDING FOR NATIONAL CANCER INSTITUTE WITH RESPECT TO RESEARCH ON BREAST CANCER.\n\nSection 408(a)(1) of the Public Health Service Act is amended to authorize funding of $300,000,000 for research on breast cancer through the National Cancer Institute for fiscal year 1994, with additional appropriations for fiscal years 1995 and 1996.\n\nSEC. 202. DUTIES OF DIRECTOR. SEC. 417. DUTIES OF DIRECTOR OF THE INSTITUTE RELATING TO BREAST CANCER RESEARCH. The Director of the Institute conducts and supports biomedical and behavioral research, research training, and health information dissemination related to breast cancer. They also conduct multidisciplinary clinical research and establish the Rose Kushner Scholarship Program for individuals attending health professions schools. The Rose Kushner Scholarship Program supports individuals attending health professions schools who agree to complete education programs, postgraduate clinical training in oncology, and serve at the National Institutes of Health in positions related to breast cancer for a specified period. The service obligation is 12 months for each academic year supported by the scholarship. The Director of the Institute may defer an individual's service obligation under the scholarship program if deemed appropriate. Individuals fulfilling their obligation at the National Institutes of Health may be appointed as employees without following standard appointment and compensation rules. Approval of a proposed academic program is required before receiving a scholarship for an academic year. The Director of the Institute may provide scholarships for academic programs, with approval required for any alterations. Recipients must maintain academic standing and scholarships are capped at $10,000 per year for tuition, educational expenses, and living expenses at health professions schools. The Director of the Institute may enter into contracts with health professions schools for scholarship payments. The program follows the same provisions as the National Health Service Corps Loan Repayment Program. Applications must be submitted to the Director in the required form. The Director of the Institute can enter contracts with health professionals for activities related to breast cancer. Professionals receive up to $20,000 annually towards educational loans in exchange for their services. Professionals must have a significant amount of educational loans relative to income to qualify for the program. The program offers up to $20,000 annually towards educational loans for health professionals with a substantial amount of educational loans relative to income. SEC. 203. SPECIALIZED PROGRAMS OF RESEARCH EXCELLENCE FOR BREAST, LUNG, AND PROSTATE CANCER. Section 408(a)(1) of the Public Health Service Act is amended to authorize appropriations for research programs on breast cancer, lung cancer, or prostate cancer for fiscal years 1994 through 1996 under the Specialized Programs of Research Excellence designated by the Director of the National Cancer Institute."
}